Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment.
暂无分享,去创建一个
S. Dutta | T. Marbury | E. Lawitz | B. Bernstein | T. Podsadecki | R. Menon | W. Awni | A. Khatri | V. Mullally | B. Ding | Amit Khatri